TARDBP and amyotrophic lateral sclerosis: This and other preclinical in vivo and in vitro evidence suggest that mutant TDP43 might play a role also in the modulation of neuroinflammatory responses in ALS, by hindering or inhibiting the phagocytic responses of reactive microglia precipitating the pathology [64].